TOP2A and non-small cell lung carcinoma: The discovery that CDK1, TOP2A, AURKA, TPX2, BUB1B, and CENPF are key cell-cycle regulators in NSCLC emphasizes the ongoing contribution of mitotic dysregulation to tumor growth.